Jazz Pharmaceuticals (JAZZ) Cash from Operations (2010 - 2026)

Jazz Pharmaceuticals' Cash from Operations history runs 17 years deep, the most recent figure standing at 408200000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 5.03% year-over-year to 408200000.0; the TTM figure through Mar 2026 stood at 1334173000.0 (down 14.39% YoY), while the FY2025 annual figure was 1355773000.0, down 2.88% from the prior year.
• Cash from Operations for Q1 2026 stood at 408200000.0, up from 362518000.0 in the prior quarter.
• The five-year high for Cash from Operations was 474616000.0 in Q3 2025, with the low at 88839000.0 in Q2 2025.
• The 5-year median for Cash from Operations is 331352000.0 (2024), against an average of 324933235.29.
• The sharpest annual moves came in 2022 and 2025: Cash from Operations jumped 626.79% in 2022, then plunged 73.19% in 2025.
• Jazz Pharmaceuticals' Cash from Operations stood at 341971000.0 in 2022, then slumped by 51.07% to 167339000.0 in 2023, then surged by 138.19% to 398580000.0 in 2024, then dropped by 9.05% to 362518000.0 in 2025, then gained by 12.6% to 408200000.0 in 2026.
• Business Quant data shows JAZZ's Cash from Operations at 408200000.0 in Q1 2026, 362518000.0 in Q4 2025, and 474616000.0 in Q3 2025.